Skip to content

Clinical trials

Neoplasm Metastasis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: South Korea Clear all

258 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20052
20069
200711
20088
200911
20105
20118
20128
201311
201413
20159
201611
20179
201813
201911
202013
202127
202221
202313
202417
202518
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Recruiting50
Active, not recruiting43
Terminated37
Unknown status27
Not yet recruiting1
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca24
Eli Lilly and Company16
Novartis Pharmaceuticals13
Samsung Medical Center11
National Cancer Center, Korea10
Pfizer8
Seoul National University Hospital7
Bayer6
Daiichi Sankyo6
Sanofi6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis258
Carcinoma, Non-Small-Cell Lung52
Breast Neoplasms49
Neoplasms46
Colorectal Neoplasms38
Stomach Neoplasms25
Lung Neoplasms22
Pancreatic Neoplasms15
Recurrence15
Squamous Cell Carcinoma of Head and Neck14

Trials

Showing 51 to 75 of 258. Each trial links to its page on Pharma Observatory.

158 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.